Asia, Western Europe, Central America, Africa, Australia, South America, Eastern Europe, Middle East, North America
All India
WHO-GMP
Product Description
Safe, effective and nonalternative in management of acute painful spasm conditions associated with degenerative or inflammatory diseases of the musculoskeletal system
tolperisone exhibited excellent tolerability in patients with spastic hypertonia following cerebral stroke
A significant reduction in the perceived intensity of jaw-muscle pain was observed with tolperisone when compared with pridinol mesylate and placebo
Tolperisone is an ideal drug for patients with chronic LBP (low back pain) as it exerts an effect on muscle blood flow by vasodilation and muscle relaxation effect